T/CACM 1353-2021 Active Group standards

T/CACM 1353-2021 The technical specifications for the design and evaluation of clinical randomized controlled trials of traditional Chinese medicine for the treatment of carotid atherosclerosis

T/CACM 1353-2021 The technical specifications for the design and evaluation of clinical randomized controlled trials of traditional Chinese medicine for the treatment of carotid atherosclerosis

Publish Date: 2021-03-16 Implement Date: 2021-03-16 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CACM 1353-2021
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Health
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2021-03-16
Implement Date: 2021-03-16

Scope

Main technical content: Preface Introduction 1 Scope 2 Normative reference documents 3 Terms and definitions 4 Design and evaluation techniques 4.1 Clinical positioning 4.2 Overall trial design 4.3 Diagnostic criteria 4.4 Differential diagnosis criteria 4.5 Subject selection and withdrawal 4.6 Drug administration scheme 4.7 Efficacy evaluation 4.8 Safety observation 4.9 Trial quality control 4.10 Ethical requirements Appendix A (informative) Diagnostic criteria for carotid artery atherosclerosis Appendix B (informative) MR imaging evaluation of carotid artery plaques Appendix C (informative) TCM differential diagnosis criteria for carotid artery atherosclerosis Appendix D (informative) Criterion-based quantitative grading list of carotid artery atherosclerosis symptoms References

Development Information

Related Standards

Contact Us